IPP Bureau
Transmural Systems wins breakthrough FDA nod for coronary-saving TAVR device
By IPP Bureau - November 27, 2025
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
Investors pile in as Cordance secures oversubscribed seed round for brain-cancer tech
By IPP Bureau - November 27, 2025
The fresh capital will propel Cordance into its first-in-human clinical trial
Glenmark launches world’s first nebulized triple therapy for COPD
By IPP Bureau - November 27, 2025
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
India’s pharma industry showcases innovation, global ambitions at CPHI & PMEC India 2025
By IPP Bureau - November 27, 2025
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Novo Nordisk fast-tracks higher-dose obesity drug to FDA
By IPP Bureau - November 27, 2025
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
Lords Mark bets big on AI-driven dialysis tech, buys 85% stake in Renalyx Health
By IPP Bureau - November 27, 2025
Renalyx will continue operating as an independent unit within the group
Dr. Lal PathLabs launches India's first complement testing lab
By IPP Bureau - November 27, 2025
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
SMS Pharmaceutical's associate company receives FDA approval for reformulated Ranitidine
By IPP Bureau - November 27, 2025
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
Zydus inks licensing, commercialisation pact with RK Pharma
By IPP Bureau - November 27, 2025
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Dhoni joins Arth by Emcure to tackle iron deficiency on World Iron Deficiency Day
By IPP Bureau - November 27, 2025
FDA updates label for Sun Pharma’s UNLOXCYT, highlighting durable responses in advanced skin cancer
By IPP Bureau - November 27, 2025
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Kelun-Biotech’s Sac-TMT shows breakthrough results in first-line lung cancer trial
By IPP Bureau - November 27, 2025
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Enlivex reports promising six-month data for Allocetra in knee osteoarthritis
By IPP Bureau - November 27, 2025
Call it a ray of hope for those enduring the pain of knee osteoarthritis -- the most common form of arthritis, affecting over 300 million people worldwide
Cidara hits target enrollment for Phase 3 flu trial ahead of peak season
By IPP Bureau - November 27, 2025
CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents
